DEFERASIROX
deferasirox 125 mg dispersible tablet, 28
DEFERASIROX (6499C)
6499C
Body System:
Manner of administration:Oral
Restriction
Indication: Chronic iron overload
Treatment phase: Initial treatment
Restriction
Indication: Chronic iron overload
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 6 | Max qty units: 168 | # of repeats: 5 | DPMQ: $626.34 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||